About the Author
My name is Mark Senak. I’m a lawyer and I work at the international communications firm FleishmanHillard in New York. For the past several years, I have been consulting with pharmaceutical and biologic companies that are engaged in the process of bringing new drugs to market. I have also worked extensively with an array of medical societies and patient organizations providing strategic communications counsel and media training.
Monthly Archives: January 2018
Weekly Roundup 1.12.18
As we ease into the new year cycle, 2018 is still waking up. Many of FDA’s web pages are not yet updated to reflect that the new year even exists. The weather is erratic, with low low temperatures one day … Continue reading
Posted in Weekly Roundup
Comments Off on Weekly Roundup 1.12.18
Advisory Committee Activity for 2017
Having worked with a lot of companies to prepare for an FDA Advisory Committee (AdComm) , I track the activities of the committees in a database marking outcomes, votes and other characteristics. As part of a look-back series as we … Continue reading
Posted in Advisory Committee Prepapartion
2 Comments
Weekly Roundup 1.5.18
Welcome to the first Weekly Roundup of the year! The fact that it was a short week and one in which the East Coast and a good deal of the South were experiencing a weather challenge means that there was … Continue reading
Posted in Weekly Roundup
Comments Off on Weekly Roundup 1.5.18
Biggest FDA Developments for 2017
As we begin the new year, it is time toassess the previous year and consider what really mattered when all is said and done. We’ve perhaps already done this on a personal level, but here is my take on an … Continue reading
Posted in FDA Image, FDA Policy
1 Comment